- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
Novavax Stock is Set to Soar in the Year Ahead
The potential rewards in NVAX stock far outweigh the risks as the vaccine maker awaits regulatory approval from the WHO and others.
Moderna Is Ready To Rally After 2-Month Market Correction
MRNA stock is ready to rally once again, as the company gears up to deliver millions of Covid-19 vaccines in 2021 and help end this…
3 Electrical Equipment Stocks to Buy Now
This week, three electrical equipment stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall…
Why Is ARCA Biopharma (ABIO) Stock Up 85% Today?
With ARCA Biopharma announcing a potentially lucrative merger with Oruka Therapeutics, ABIO stock skyrocketed on the news.
FDA Approves Ecstasy Trials for PTSD Sufferers
The Food and Drug Administration (FDA) has approved clinical trials for ecstasy to treat PTSD sufferers, including police and firefighters.
Novavax: Big Market Potential, Meaningful Stock Upside
Even after a 5,690% gain, NVAX stock looks positioned for further upside with the firm’s focus on bringing vaccines to low-income countries.
Novavax Stock Is Poised to Climb Further
NVAX stock seems positioned for further gains with the firm’s vaccine deliveries set to begin in early 2022.
Pfizer Looks Like Good Value With Its Vaccine Catalyst and Dividend Yield
Pfizer looks like good value with its vaccine catalyst and dividend yield. PFE stock will be 60% higher within several years after the FDA grants…
Moderna Is a Great Investment Despite Short-Term Headwinds
Following the FDA approval of its vaccine, MRNA stock is set to make some big gains on distribution deals across the globe.
If You’re Placing Bets on Vaccine Winners, Novavax Ought to Be on Your List
Novavax got a manufacturing partner in mid-September to make 2 billion doses. Despite NVAX stock going sideways since then, it remains a buy.
Ocugen Looks Very Dicey at Current Levels
Ocugen believes it can distribute 100 million doses of a Covid-19 vaccine in the U.S. But this looks like a long shot for OCGN stock.
GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal
GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.
Looking for Great Bank Stocks to Buy? Look North.
Canadian bank stocks offer plenty of upside … and a good dose of safety to boot. Check out these 3 Canadian bank stocks to buy…
3 Stocks to Watch on Monday: Apple Inc. (AAPL), Microsoft Corporation (MSFT) and Electronic Arts Inc. (EA)
E3 news from Microsoft (MSFT) and Electronic Arts (EA) dominated the weekend, but Apple (AAPL) will kick off Monday with a dose of reality.
5 Exotic ETFs to Buy for a Better Portfolio in 2019
A dose of out of box ETFs could do your portfolio good next year. Here are five great choices to build a better portfolio.
Novavax Stock Leads the Board on Wall Street but Lags on Main Street
NVAX stock is up over 3,000% this year yet it’s not the one with the doses on the streets. Best to trade the stock while…
Memo to Bill Gross: The U.S. Is Not Greece
Once again, Pimco’s boss offers a big dose of unhelpful opinion, and his lumping the U.S. in with Greece and Spain is just plain wrong.
3 Electrical Equipment Stocks to Buy Now
Three electrical equipment stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded…
Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
GW Pharmaceuticals PLC- ADR Is a First-Rate Marijuana Stock (GWPH)
GW Pharmaceuticals (GWPH) brings credibility to a movement that would otherwise have none of its own. GWPH stock belongs on your watch list.
After the Latest Plunge, Catalyst Stock Just Might Be Worth Buying
Disappointing results from one of Catalyst Biosciences’ clinical studies spooked investors. Though the share sell-off in Catalyst stock created paper losses for speculators, the company…
Novavax Stock Is Alluringly Attractive at This Stage
Novavax is close to securing FDA approval for its Covid-19 vaccine yet NVAX stock is down since the end of January. What gives?
6 – 10 of 240 results
